Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Beauty Health Company stock logo
SKIN
Beauty Health
$1.59
-4.2%
$1.75
$0.78
$2.38
$200.33M1.22942,705 shs466,393 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$3.66
-4.4%
$3.75
$0.52
$5.92
$241.98M1.85853,224 shs516,954 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$8.44
-2.5%
$9.05
$8.15
$22.18
$235.03M2.07178,376 shs201,418 shs
Zynex Inc. stock logo
ZYXI
Zynex
$2.31
-1.7%
$2.33
$1.66
$10.47
$69.85M0.83174,686 shs70,109 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Beauty Health Company stock logo
SKIN
Beauty Health
0.00%-16.75%+8.90%+87.99%-23.56%
Neuronetics, Inc. stock logo
STIM
Neuronetics
0.00%+2.52%+8.28%-2.66%+83.00%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%-6.22%-1.97%-10.12%-55.44%
Zynex Inc. stock logo
ZYXI
Zynex
0.00%+3.12%-4.15%+5.96%-77.59%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Beauty Health Company stock logo
SKIN
Beauty Health
0.4102 of 5 stars
0.80.00.00.02.73.30.0
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.8354 of 5 stars
3.31.00.00.01.91.70.6
ZimVie Inc. stock logo
ZIMV
ZimVie
2.1209 of 5 stars
3.32.00.00.01.91.70.6
Zynex Inc. stock logo
ZYXI
Zynex
2.0557 of 5 stars
3.20.00.00.01.61.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Beauty Health Company stock logo
SKIN
Beauty Health
1.67
Reduce$1.42-10.90% Downside
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.67
Moderate Buy$5.5050.27% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.67
Moderate Buy$16.3393.52% Upside
Zynex Inc. stock logo
ZYXI
Zynex
2.33
Hold$5.50138.10% Upside

Current Analyst Ratings Breakdown

Latest ZYXI, STIM, ZIMV, and SKIN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/15/2025
Zynex Inc. stock logo
ZYXI
Zynex
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$4.00 ➝ $3.00
6/30/2025
Zynex Inc. stock logo
ZYXI
Zynex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
5/15/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $10.00
5/5/2025
The Beauty Health Company stock logo
SKIN
Beauty Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$1.50 ➝ $1.25
4/30/2025
Zynex Inc. stock logo
ZYXI
Zynex
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$5.00 ➝ $4.00
4/30/2025
Zynex Inc. stock logo
ZYXI
Zynex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $8.00
(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Beauty Health Company stock logo
SKIN
Beauty Health
$322.47M0.62$0.06 per share25.15$0.41 per share3.88
Neuronetics, Inc. stock logo
STIM
Neuronetics
$74.89M3.23N/AN/A$0.57 per share6.42
ZimVie Inc. stock logo
ZIMV
ZimVie
$443.55M0.53$1.86 per share4.54$13.83 per share0.61
Zynex Inc. stock logo
ZYXI
Zynex
$172.40M0.41$0.24 per share9.46$1.12 per share2.06
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Beauty Health Company stock logo
SKIN
Beauty Health
-$29.10M-$0.41N/AN/AN/A-11.94%-67.91%-5.56%8/6/2025 (Estimated)
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$43.71M-$1.31N/AN/AN/A-53.67%-174.15%-38.41%8/11/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.71N/AN/A-4.40%5.53%2.84%8/7/2025 (Estimated)
Zynex Inc. stock logo
ZYXI
Zynex
$2.99M-$0.24N/A4.91N/A-4.30%-23.70%-6.23%7/23/2025 (Estimated)

Latest ZYXI, STIM, ZIMV, and SKIN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
The Beauty Health Company stock logo
SKIN
Beauty Health
-$0.06N/AN/AN/AN/AN/A
8/11/2025Q2 2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.08N/AN/AN/A$36.80 millionN/A
8/7/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.2285N/AN/AN/A$112.82 millionN/A
7/23/2025Q2 2025
Zynex Inc. stock logo
ZYXI
Zynex
-$0.20N/AN/AN/A$27.38 millionN/A
5/8/2025Q1 2025
The Beauty Health Company stock logo
SKIN
Beauty Health
-$0.13-$0.08+$0.05-$0.08$63.88 million$69.60 million
5/8/2025Q1 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.21$0.27+$0.06-$0.05$113.10 million$112.00 million
5/6/2025Q1 2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.13-$0.21-$0.08-$0.21$29.07 million$31.98 million
4/28/2025Q1 2025
Zynex Inc. stock logo
ZYXI
Zynex
-$0.24-$0.33-$0.09-$0.33$30.83 million$26.58 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Beauty Health Company stock logo
SKIN
Beauty Health
N/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
Zynex Inc. stock logo
ZYXI
Zynex
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Beauty Health Company stock logo
SKIN
Beauty Health
12.01
7.47
6.43
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.40
2.44
2.28
ZimVie Inc. stock logo
ZIMV
ZimVie
0.58
2.14
1.48
Zynex Inc. stock logo
ZYXI
Zynex
2.87
3.46
2.63

Institutional Ownership

CompanyInstitutional Ownership
The Beauty Health Company stock logo
SKIN
Beauty Health
93.26%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%
Zynex Inc. stock logo
ZYXI
Zynex
29.68%

Insider Ownership

CompanyInsider Ownership
The Beauty Health Company stock logo
SKIN
Beauty Health
41.00%
Neuronetics, Inc. stock logo
STIM
Neuronetics
8.70%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
Zynex Inc. stock logo
ZYXI
Zynex
49.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
The Beauty Health Company stock logo
SKIN
Beauty Health
1,030125.99 million74.34 millionOptionable
Neuronetics, Inc. stock logo
STIM
Neuronetics
18066.11 million60.36 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77027.85 million27.01 millionOptionable
Zynex Inc. stock logo
ZYXI
Zynex
77030.24 million15.34 millionOptionable

Recent News About These Companies

Zynex: New CEO Steven Dyson shares his vision – ICYMI
Zynex: New CEO Steven Dyson shares his vision – ICYMI
Tricare Temporary Payment Suspension Update
Zynex appoints Steven Dyson as new CEO
Zynex taps Steve Dyson as chief executive officer
Zynex Announces Steven Dyson as New CEO
Zynex Announces Workforce Reduction
Here’s Why Zynex (ZYXI) Fell in Q1

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Beauty Health stock logo

Beauty Health NASDAQ:SKIN

$1.59 -0.07 (-4.22%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$1.61 +0.02 (+1.26%)
As of 07/18/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

Neuronetics stock logo

Neuronetics NASDAQ:STIM

$3.66 -0.17 (-4.44%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.70 +0.04 (+1.23%)
As of 07/18/2025 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$8.44 -0.22 (-2.54%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$8.44 0.00 (-0.06%)
As of 07/18/2025 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

Zynex stock logo

Zynex NASDAQ:ZYXI

$2.31 -0.04 (-1.70%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$2.32 +0.01 (+0.43%)
As of 07/18/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.